TOR3A represses type I interferon production and limits viral clearance during respiratory syncytial virus infection
Xiaoping Li, Zhengrong Chen, Mengyun Wu, Peijie Zhu, Guodong Qiao, Jiaoyang Li, Yunfei Ye, Jiamin Cai, Ying Zhou, Xiaoqiu Dai, Yufeng Wang, Cancheng Li, Jiaqi Huang, Ji Zhou, Fei Xu, Chensheng Tan, Yu Shao, Xiu Gao, Jingjing Hu, Xuena Xu, Chunsheng Dong, Chuangli Hao, Yi Yang, Jinping Zhang
Journal:Emerging Microbes & Infections
IF:7.5
DOI:10.1080/22221751.2026.2637961
PMID:
Published:2026-03-13
research field:分子生物学免疫学病毒学
Abstract
Type I interferons (IFN-I) are essential for antiviral immunity, and precise regulation of IFN-I production is crucial to balance viral clearance and immunopathology. Here, we demonstrate that the interferon-stimulated gene TOR3A negatively regulates type I IFN signalling during respiratory syncytial virus (RSV) infection. TOR3A expression was upregulated in macrophages and RSV-infected patients, and its deficiency enhanced antiviral responses, leading to reduced viral load. Mechanistically, RSV infection induced TOR3A expression through the IFN-STAT1 pathway, which in turn suppressed IFN-I production. Furthermore, TOR3A recruited the E3 ubiquitin ligase STUB1 to mediate K48-linked ubiquitination and proteasomal degradation of RIG-I at lysine 146, thereby promoting RSV immune evasion. Our study identifies TOR3A as a novel suppressor of antiviral immunity and uncovers a mechanism by which RSV exploits host ISGs to dampen IFN-I responses, providing new insights into viral pathogenesis and potential therapeutic strategies.
本文使用的Yeasen产品


